# Canberra Corporation – FDA Inspection, Mar 26, 2014

Source: https://www.keypedia.com/records/fda_inspections/canberra-corporation/4d5af0b3-a1ff-4a9b-aada-1fe63ca8601f
Source feed: FDA_Inspections

> FDA inspection 871450 of Canberra Corporation, March 26, 2014. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 871450
- Company Name: Canberra Corporation
- Inspection Date: 2014-03-26
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 816541 - 2013-02-21](https://www.keypedia.com/records/fda_inspections/canberra-corporation/5a37867f-6e32-4061-a3c4-baee1061c23b)
- FDA Inspection 683537 - 2010-09-14
- FDA Inspection 674022 - 2010-08-11
- [FDA Inspection 648844 - 2010-03-03](https://www.keypedia.com/records/fda_inspections/canberra-corporation/bc8dbc82-50d6-4db1-8541-e155e006981a)

Company: https://www.keypedia.com/companies/canberra-corporation/897a38d1-12e3-4b70-8e88-2bcc4eaf0fc6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c